Publications by authors named "M I Al-Jarallah"
Background: Emerging evidence from various countries suggests that ST-segment elevation myocardial infarction (STEMI) patients with differing health-care insurance types experience discrepancies in clinical management and outcomes. Kuwait government provides free essential treatments and medications to noninsured patients with certain emergency conditions. We aimed to compare differences in clinical management and in-hospital and 30-day outcomes in STEMI patients with different insurance types in Kuwait.
View Article and Find Full Text PDFObjectives: To evaluate the prognostic value (total mortality + repeated hospitalization for heart failure (HF)) of ultrasound diagnostic methods in patients with acute decompensated HF (ADHF).
Methods: The subjects were patients with chronic HF, who were hospitalized for ADHF. Using ultrasound methods-lung ultrasound, ultrasound assessment of hepatic venous congestion as per the venous excess ultrasound (VExUS) protocol, and indirect elastometry-we assessed the number of B-lines, hepatic venous congestion, and liver density of the patients.
Article Synopsis
- This study focused on acute myocardial infarction complicated by cardiogenic shock (AMI-CS) in the Gulf region, addressing a lack of data by analyzing 1,513 patients from 2020 to 2022.
- The incidence of AMI-CS was found to be 4.1%, with a high in-hospital mortality rate of 45.5%, and patients primarily presented with ST-elevation MI.
- Key risk factors for increased hospital mortality included previous coronary artery bypass grafts, chronic kidney disease, and SCAI shock stages D and E, with a 12-month survival rate of 51.49%.*
Background: The dimensionless Rajan's heart failure (R-hf) risk score was proposed to predict all-cause mortality in patients hospitalized with chronic heart failure (HF) and reduced ejection fraction (EF) (HFrEF).
Purpose: To examine the association between the modified R-hf risk score and all-cause mortality in patients with HFrEF.
Methods: Retrospective cohort study included adults hospitalized with HFrEF, as defined by clinical symptoms of HF with biplane EF less than 40% on transthoracic echocardiography, at a tertiary centre in Dalian, China, between 1 November 2015, and 31 October 2019.
Background: Chronic kidney disease (CKD) is a common comorbid condition in patients undergoing transcatheter aortic valve replacement (TAVR). Reported outcome studies on the association of baseline CKD and mortality is currently limited.
Objectives: To determine the prevalence of chronic kidney disease in patients undergoing TAVR and analyse their overall procedural outcomes.